Interleukin 1β Gene Single-Nucleotide Polymorphisms and Susceptibility to Pancreatic Neuroendocrine Tumors
Abstract
Pancreatic neuroendocrine tumors (pNETs) are rare neoplasms with not fully understood etiology. Interleukin 1β (IL1β) plays an important role in pancreatic pathology, especially carcinogenesis, but its role in pNET development remains unknown. The aim of this study was to analyze the association between IL1β polymorphisms and susceptibility to pNETs. IL1β −511 C/T and +3954 C/T single-nucleotide polymorphisms (SNPs) were analyzed by real-time polymerase chain reaction–SNP analysis. IL1β serum values in pNET patients were also determined. Association between high-expression C/T −511 IL1β genotype and susceptibility to pNET (p=0.042) was found, especially with functional pNET (p=0.014), where it was associated with the T allele (p=0.016). Combination of genotype analyses confirmed carriers of −511/+3954 CTCT to be at risk of developing functional pNETs (p=0.006) and carriers of −511/+3954 CTCC at risk of developing nonfunctional pNETs (p=0.019). IL1β serum levels of all patients were below the limit of detection. Our results suggest IL1β involvement in pNET development, and we also found association between the IL1β −511 SNP and susceptibility to pNET, especially functional pNETs. Nonfunctional pNETs seem to have inferior prognosis when compared with functional pNETs. It is possible that they differ in tumor microenvironment and that nonfunctional tumors share similarities with adenocarcinoma. We believe that our findings will contribute to understanding of the etiology and possible novel prognostic markers for pNETs when future studies investigating the serum and tumor tissue IL1β levels are done.
Get full access to this article
View all available purchase options and get full access to this article.
References
Abdul M.Hoosein N.2002. Relationship of the interleukin-1 system with neuroendocrine and exocrine markers in human colon cancer cell linesCytokine1886-91. Abdul, M., and Hoosein, N. (2002). Relationship of the interleukin-1 system with neuroendocrine and exocrine markers in human colon cancer cell lines. Cytokine 18, 86–91.
Ankarcrona M.Dypbukt J.M.Brune B.Nicotera P.1994. Interleukin-1β-induced nitric oxide production activates apoptosis in pancreatic RINm5F cellsExp Cell Res213172-177. Ankarcrona, M., Dypbukt, J.M., Brune, B., and Nicotera, P. (1994). Interleukin-1β-induced nitric oxide production activates apoptosis in pancreatic RINm5F cells. Exp Cell Res 213, 172–177.
Apte R.N.Dotan S.Elkabets M.White M.R.Reich E.Carmi Y.Song X.Dvozkin T.Krelin Y.Voronov E.2006. The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor–host interactionsCancer Metastasis Rev25387-408. Apte, R.N., Dotan, S., Elkabets, M., White, M.R., Reich, E., Carmi, Y., Song, X., Dvozkin, T., Krelin, Y., and Voronov, E. (2006). The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor–host interactions. Cancer Metastasis Rev 25, 387–408.
Barber M.D.Powell J.J.Lynch S.F.Fearon K.C.Ross J.A.2000. A polymorphism of the interleukin-1 beta gene influences survival in pancreatic cancerBr J Cancer831443-1447. Barber, M.D., Powell, J.J., Lynch, S.F., Fearon, K.C., and Ross, J.A. (2000). A polymorphism of the interleukin-1 beta gene influences survival in pancreatic cancer. Br J Cancer 83, 1443–1447.
Chan A.O.Kim S.G.Bedeir A.Issa J.P.Hamilton S.R.Rashid A.2003. CpG island methylation in carcinoid and pancreatic endocrine tumorsOncogene22924-934. Chan, A.O., Kim, S.G., Bedeir, A., Issa, J.P., Hamilton, S.R., and Rashid, A. (2003). CpG island methylation in carcinoid and pancreatic endocrine tumors. Oncogene 22, 924–934.
Chen G.Hohmeier H.E.Newgard C.B.2001. Expression of the Transcription Factor STAT-1α in Insulinoma Cells Protects against Cytotoxic Effects of Multiple CytokinesJ Biol Chem276766-772. Chen, G., Hohmeier, H.E., and Newgard, C.B. (2001). Expression of the Transcription Factor STAT-1α in Insulinoma Cells Protects against Cytotoxic Effects of Multiple Cytokines. J Biol Chem 276, 766–772.
Chen H.Wilkins L.M.Aziz N.Cannings C.Wyllie D.H.Bingle C.Rogus J.Beck J.D.Offenbacher S.Cork M.J.Rafie-Kolpin M.Hsieh C.M.Kornman K.S.Duff G.W.2006. Single nucleotide polymorphisms in the human interleukin-1B gene affect transcription according to haplotype contextHum Mol Genet15519-529. Chen, H., Wilkins, L.M., Aziz, N., Cannings, C., Wyllie, D.H., Bingle, C., Rogus, J., Beck, J.D., Offenbacher, S., Cork, M.J., Rafie-Kolpin, M., Hsieh, C.M., Kornman, K.S., and Duff, G.W. (2006). Single nucleotide polymorphisms in the human interleukin-1B gene affect transcription according to haplotype context. Hum Mol Genet 15, 519–529.
Corbett J.A.Sweetland M.A.Wang J.L.Lancaster J.R.McDaniel M.L.1993. Nitric oxide mediates cytokine-induced inhibition of insulin secretion by human islets of LangerhansProc Natl Acad Sci U S A901731-1735. Corbett, J.A., Sweetland, M.A., Wang, J.L., Lancaster, J.R., and McDaniel, M.L. (1993). Nitric oxide mediates cytokine-induced inhibition of insulin secretion by human islets of Langerhans. Proc Natl Acad Sci U S A 90, 1731–1735.
Deans D.A.Wigmore S.J.Gilmour H.Paterson-Brown S.Ross J.A.Fearon K.C.2006. Elevated tumour interleukin-1beta is associated with systemic inflammation: a marker of reduced survival in gastro-oesophageal cancerBr J Cancer951568-1575. Deans, D.A., Wigmore, S.J., Gilmour, H., Paterson-Brown, S., Ross, J.A., and Fearon, K.C. (2006). Elevated tumour interleukin-1beta is associated with systemic inflammation: a marker of reduced survival in gastro-oesophageal cancer. Br J Cancer 95, 1568–1575.
Ebrahimi B.Tucker S.L.Li D.Abbruzzese J.L.Kurzrock R.2004. Cytokines in pancreatic carcinoma: correlation with phenotypic characteristics and prognosisCancer1012727-2736. Ebrahimi, B., Tucker, S.L., Li, D., Abbruzzese, J.L., and Kurzrock, R. (2004). Cytokines in pancreatic carcinoma: correlation with phenotypic characteristics and prognosis. Cancer 101, 2727–2736.
El-Omar E.M.Carrington M.Chow W.H.McColl K.E.Bream J.H.Young H.A.Herrera J.Lissowska J.Yuan C.C.Rothman N.Lanyon G.Martin M.Fraumeni J.F. Jr.Rabkin C.S.2000. Interleukin-1 polymorphisms associated with increased risk of gastric cancerNature404398-402. El-Omar, E.M., Carrington, M., Chow, W.H., McColl, K.E., Bream, J.H., Young, H.A., Herrera, J., Lissowska, J., Yuan, C.C., Rothman, N., Lanyon, G., Martin, M., Fraumeni, J.F., Jr., and Rabkin, C.S. (2000). Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 404, 398–402.
Franko J.Feng W.Yip L.Genovese E.Moser A.J.2010. Non-functional neuroendocrine carcinoma of the P pancreas: incidence, tumor biology, and outcomes in 2,158 patientsJ Gastrointest Surg14541-548. Franko, J., Feng, W., Yip, L., Genovese, E., and Moser, A.J. (2010). Non-functional neuroendocrine carcinoma of the P pancreas: incidence, tumor biology, and outcomes in 2,158 patients. J Gastrointest Surg 14, 541–548.
Greco E.Basso D.Fogar P.Mazza S.Navaglia F.Zambon C.F.Falda A.Pedrazzoli S.Ancona E.Plebani M.2005. Pancreatic cancer cells invasiveness is mainly affected by interleukin-1beta not by transforming growth factor-beta1Int J Biol Markers20235-241. Greco, E., Basso, D., Fogar, P., Mazza, S., Navaglia, F., Zambon, C.F., Falda, A., Pedrazzoli, S., Ancona, E., and Plebani, M. (2005). Pancreatic cancer cells invasiveness is mainly affected by interleukin-1beta not by transforming growth factor-beta1. Int J Biol Markers 20, 235–241.
Hamacher R.Diersch S.Scheibel M.Eckel F.Mayr M.Rad R.Bajbouj M.Schmid R.M.Saur D.Schneider G.2009. Interleukin 1 beta gene promoter SNPs are associated with risk of pancreatic cancerCytokine46182-186. Hamacher, R., Diersch, S., Scheibel, M., Eckel, F., Mayr, M., Rad, R., Bajbouj, M., Schmid, R.M., Saur, D., and Schneider, G. (2009). Interleukin 1 beta gene promoter SNPs are associated with risk of pancreatic cancer. Cytokine 46, 182–186.
House M.G.Herman J.G.Guo M.Z.Hooker C.M.Schulick R.D.Cameron J.L.Hruban R.H.Maitra A.Yeo C.J.2003. Prognostic value of hMLH1 methylation and microsatellite instability in pancreatic endocrine neoplasmsSurgery134902-908. House, M.G., Herman, J.G., Guo, M.Z., Hooker, C.M., Schulick, R.D., Cameron, J.L., Hruban, R.H., Maitra, A., and Yeo, C.J. (2003). Prognostic value of hMLH1 methylation and microsatellite instability in pancreatic endocrine neoplasms. Surgery 134, 902–908.
Massironi S.Sciola V.Peracchi M.Ciafardini C.Spampatti M.P.Conte D.2008. Neuroendocrine tumors of the gastro-entero-pancreatic systemWorld J Gastroenterol145377-5384. Massironi, S., Sciola, V., Peracchi, M., Ciafardini, C., Spampatti, M.P., and Conte, D. (2008). Neuroendocrine tumors of the gastro-entero-pancreatic system. World J Gastroenterol 14, 5377–5384.
Muerkoster S.Wegehenkel K.Arlt A.Witt M.Sipos B.Kruse M.L.Sebens T.Kloppel G.Kalthoff H.Folsch U.R.Schafer H.2004. Tumor stroma interactions induce chemoresistance in pancreatic ductal carcinoma cells involving increased secretion and paracrine effects of nitric oxide and interleukin-1betaCancer Res641331-1337. Muerkoster, S., Wegehenkel, K., Arlt, A., Witt, M., Sipos, B., Kruse, M.L., Sebens, T., Kloppel, G., Kalthoff, H., Folsch, U.R., and Schafer, H. (2004). Tumor stroma interactions induce chemoresistance in pancreatic ductal carcinoma cells involving increased secretion and paracrine effects of nitric oxide and interleukin-1beta. Cancer Res 64, 1331–1337.
Pociot F.Molvig J.Wogensen L.Worsaae H.Nerup J.1992. A TaqI polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitroEur J Clin Invest22396-402. Pociot, F., Molvig, J., Wogensen, L., Worsaae, H., and Nerup, J. (1992). A TaqI polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro. Eur J Clin Invest 22, 396–402.
Spaventi R.Pečur L.Pavelić K.Pavelić Z.P.Spaventi S.Stambrook P.J.1994. Human tumor bank in Croatia: a possible model for a small bank as a part of the future European Tumor Bank NetworkEur J Cancer30A419. Spaventi, R., Pečur, L., Pavelić, K., Pavelić, Z.P., Spaventi, S., and Stambrook, P.J. (1994). Human tumor bank in Croatia: a possible model for a small bank as a part of the future European Tumor Bank Network. Eur J Cancer 30A, 419.
ten Kate M.Hofland L.J.van Koetsveld P.M.Jeekel J.van Eijck C.H.2006. Pro-inflammatory cytokines affect pancreatic carcinoma cellEndothelial Cell Interact7454-464. ten Kate, M., Hofland, L.J., van Koetsveld, P.M., Jeekel, J., and van Eijck, C.H. (2006). Pro-inflammatory cytokines affect pancreatic carcinoma cell. Endothelial Cell Interact 7, 454–464.
Wang Y.Kato N.Hoshida Y.Yoshida H.Taniguchi H.Goto T.Moriyama M.Otsuka M.Shiina S.Shiratori Y.Ito Y.Omata M.2003. Interleukin-1beta gene polymorphisms associated with hepatocellular carcinoma in hepatitis C virus infectionHepatology3765-71. Wang, Y., Kato, N., Hoshida, Y., Yoshida, H., Taniguchi, H., Goto, T., Moriyama, M., Otsuka, M., Shiina, S., Shiratori, Y., Ito, Y., and Omata, M. (2003). Interleukin-1beta gene polymorphisms associated with hepatocellular carcinoma in hepatitis C virus infection. Hepatology 37, 65–71.
Yoshida N.Ikemoto S.Narita K.Sugimura K.Wada S.Yasumoto R.Kishimoto T.Nakatani T.2002. Interleukin-6, tumour necrosis factor alpha and interleukin-1beta in patients with renal cell carcinomaBr J Cancer861396-1400. Yoshida, N., Ikemoto, S., Narita, K., Sugimura, K., Wada, S., Yasumoto, R., Kishimoto, T., and Nakatani, T. (2002). Interleukin-6, tumour necrosis factor alpha and interleukin-1beta in patients with renal cell carcinoma. Br J Cancer 86, 1396–1400.
Zienolddiny S.Ryberg D.Maggini V.Skaug V.Canzian F.Haugen A.2004. Polymorphisms of the interleukin-1 beta gene are associated with increased risk of non-small cell lung cancerInt J Cancer109353-356. Zienolddiny, S., Ryberg, D., Maggini, V., Skaug, V., Canzian, F., and Haugen, A. (2004). Polymorphisms of the interleukin-1 beta gene are associated with increased risk of non-small cell lung cancer, Int J Cancer 109, 353–356.
Information & Authors
Information
Published In

Copyright
Copyright 2012, Mary Ann Liebert, Inc.
History
Published online: 13 April 2012
Published in print: April 2012
Published ahead of print: 11 October 2011
Accepted: 16 August 2011
Revision received: 16 August 2011
Received: 9 May 2011
Authors
Disclosure Statement
The authors confirm that no conflict of interest exists in this study.
Metrics & Citations
Metrics
Citations
Export Citation
Export citation
Select the format you want to export the citations of this publication.
View Options
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.⚠ Society Access
If you are a member of a society that has access to this content please log in via your society website and then return to this publication.